Ecological risk assessment of the presence of pharmaceutical residues in a French national water survey

Regulatory Toxicology and Pharmacology

Volumn 69, Issue 3, 2014, Pages 296-303

  Bouissou Schurtz, Camille ^a   Houeto, Paul ^a   Guerbet, Michel ^b   Bachelot, Morgane ^c   Casellas, Claude ^c   Mauclaire, Anne Cécile ^a   Panetier, Pascale ^d   Delval, Cécile ^a   Masset, Dominique ^a  

^a Service de pharmacovigilance   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d FRENCH AGENCY FOR FOOD   (France)

Author keywords

Environment; Pharmaceuticals; Risk assessment; Water resource

Indexed keywords

AMLODIPINE; AMOXICILLIN; ATENOLOL; CAFFEINE; CARBAMAZEPINE; CYCLOPHOSPHAMIDE; DICLOFENAC; DOXYCYCLINE; DRUG RESIDUE; ERYTHROMYCIN; ESTRADIOL; ESTRONE; FLUVOXAMINE; FUROSEMIDE; GADOLINIUM; HYDROCHLOROTHIAZIDE; IBUPROFEN; KETOPROFEN; LEVONORGESTREL; LOSARTAN; NAFTIDROFURYL; OXAZEPAM; PARACETAMOL; PRAVASTATIN; PROGESTERONE; RAMIPRIL; RANITIDINE; SALICYLIC ACID; TRIMETAZIDINE; UNINDEXED DRUG; DRUG; WATER; WATER POLLUTANT;

ARTICLE; CONCENTRATION (PARAMETERS); ECOTOXICITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; ENVIRONMENTAL PARAMETERS; HUMAN; MEASURED ENVIRONMENTAL CONCENTRATION; NONHUMAN; PREDICTED ENVIRONMENTAL CONCENTRATION; PREDICTED NO EFFECT CONCENTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; WATER POLLUTION; CHEMISTRY; ENVIRONMENTAL MONITORING; PROCEDURES; WATER POLLUTANT;

ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84904047702     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2014.04.006     Document Type: Article

References (53)

1. Andreozzi R., Marotta R., Pinto G., Pollio A. Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res. 2002, 36(11):2869-2877.
2. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50(10):1319-1330.
3. ANSES, 2011. Campagne nationale d'occurrence des résidus de médicaments dans les eaux destinées à la consommation humaine. Available from: <>. http://www.anses.fr/sites/default/files/documents/LABO-Ra-EtudeMedicamentsEaux.pdf.
4. Besse J.P., Kausch-Barreto C., Garric J. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the french situation and preliminary prioritization. Human Ecol. Risk Assess. 2008, 14:665-695.
5. Besse J.P., Garric J. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. Toxicol. Lett. 2008, 176(2):104-123.
6. Bound J.P., Voulvoulis N. Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment. Water Res. 2006, 40(15):2885-2892.
7. Brodin T., Fick J., Jonsson M., Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 2013, 339(6121):814-815.
8. Calleja M.C., Geladi P., Persoone G. Modelling of human acute toxicity from physicochemical properties and non-vertebrate acute toxicity of the 38 organic chemicals of the MEIC priority list by PLS regression and neural network. Food Chem. Toxicol. 1994, 32(10):923-941.
9. Calleja M.C., Persoone G., Geladi P. Human acute toxicity prediction of the first 50 MEIC chemicals by a battery of ecotoxicological tests and physicochemical properties. Food Chem. Toxicol. 1994, 32(2):173-187.
10. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kühler T. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci. Total Environ. 2006, 364(1-3):67-87.
11. Choi K., Kim Y., Park J., Park C.K., Kim M., Kim H.S., Kim P. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci. Total Environ. 2008, 405(1-3):120-128.
12. Conley J.M., Symes S.J., Kindelberger S.A., Richards S.M. Rapid liquid chromatography-tandem mass spectrometry method for the determination of a broad mixture of pharmaceuticals in surface water. J. Chromatogr. A 2008, 1185(2):206-215.
13. Cuklev F., Fick J., Cvijovic M., Kristiansson E., Förlin L., Larsson D.G. Does ketoprofen or diclofenac pose the lowest risk to fish?. J. Hazard. Mater. 2012, 229-230:100-106.
14. David A., Pancharatna K. Developmental anomalies induced by a non-selective COX inhibitor (ibuprofen) in zebrafish (Danio rerio). Environ. Toxicol. Pharmacol. 2009, 27(3):390-395.
15. David A., Pancharatna K. Effects of acetaminophen (acetaminophen) in the embryonic development of zebrafish, Danio rerio. J. Appl. Toxicol. 2009, 29(7):597-602.
16. Donner E., Kosjek T., Qualmann S., Kusk K.O., Heath E., Revitt D.M., Ledin A., Andersen H.R. Ecotoxicity of carbamazepine and its UV photolysis transformation products. Sci. Total Environ. 2013, 443:870-876.
17. EMA, 2006. European medicine agency guideline on the environmental risk assessment of medicinal products for human use (EMEA/CHMP/SWP/4447/00). Available from: <>. http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500003978.
18. Farré M.L., Ferrer I., Ginebreda A., Figueras M., Olivella L., Tirapu L., Vilanova M., Barceló D. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J. Chromatogr. A 2001, 938(1-2):187-197.
19. Fenet H., Mathieu O., Mahjoub O., Li Z., Hillaire-Buys D., Casellas C., Gomez E. Carbamazepine, carbamazepine epoxide and dihydroxycarbamazepine sorption to soil and occurrence in a wastewater reuse site in Tunisia. Chemosphere 2012, 88(1):49-54.
20. Ferrari B., Paxéus N., Lo Giudice R., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Saf. 2003, 55(3):359-370.
21. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer M.T., Zaugg S.D., Barber L.B., Thurman M.E. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States-II) untreated drinking water sources. Sci. Total Environ. 2008, 402(2-3):201-216.
22. Galus M., Jeyaranjaan J., Smith E., Li H., Metcalfe C., Wilson J.Y. Chronic effects of exposure to a pharmaceutical mixture and municipal wastewater in zebrafish. Aquat. Toxicol. 2013, 132-133(15):212-222.
23. Galus M., Kirischian N., Higgins S., Purdy J., Chow J., Rangaranjan S., Li H., Metcalfe C., Wilson J.Y. Chronic, low concentration exposure to pharmaceuticals impacts multiple organ systems in zebrafish. Aquat. Toxicol. 2013, 132-133(15):200-211.
24. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36(2):357-393.
25. Han G.H., Hur H.G., Kim S.D. Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna. Environ. Toxicol. Chem. 2006, 25(1):265-271.
26. Han S., Choi K., Kim J., Ji K., Kim S., Ahn B., Yun J., Choi K., Khim J.S., Zhang X., Giesy J.P. Endocrine disruption and consequences of chronic exposure to ibuprofen in Japanese medaka (Oryzias latipes) and freshwater cladocerans Daphnia magna and Moina macrocopa. Aquat. Toxicol. 2010, 98(3):256-264.
27. Hayashi Y., Heckmann L.H., Callaghan A., Sibly R.M. Reproduction recovery of the crustacean Daphnia magna after chronic exposure to ibuprofen. Ecotoxicology 2008, 17(4):246-251.
28. Henschel K.P., Wenzel A., Diedrich M., Fliedner A. Environmental hazard assessment of pharmaceuticals. Regul. Toxicol. Pharmacol. 1997, 25(3):220-225.
29. Houeto P., Carton A., Guerbet M., Mauclaire A.C., Gatignol C., Lechat P., Masset D. Assessment of the health risks related to the presence of drug residues in water for human consumption: application to carbamazepine. Regul. Toxicol. Pharmacol. 2012, 62(1):41-48.
30. Kavitha C., Malarvizhi A., Senthil Kumaran S., Ramesh M. Toxicological effects of arsenate exposure on hematological, biochemical and liver transaminases activity in an Indian major carp, Catla catla. Food Chem. Toxicol. 2010, 48(10):2848-2854.
31. Kim P., Park Y., Ji K., Seo J., Lee S., Choi K., Kho Y., Park J., Choi K. Effect of chronic exposure to acetaminophen and lincomycin on Japanese medaka (Oryzias latipes) and freshwater cladocerans Daphnia magna and Moina macrocopa, and potential mechanisms of endocrine disruption. Chemosphere 2012, 89(1):10-18.
32. Kristensen D.M., Lesné L., Le Fol V., Desdoits-Lethimonier C., Dejucq-Rainsford N., Leffers H., Jégou B. Paracetamol (acetaminophen), aspirin (acetylsalicylic acid) and indomethacin are anti-androgenic in the rat foetal testis. Int. J. Androl. 2012, 35(3):377-384.
33. Kristensen D.M., Skalkam M.L., Audouze K., Lesné L., Desdoits-Lethimonier C., Frederiksen H., Brunak S., Skakkebæk N.E., Jégou B., Hansen J.B., Junker S., Leffers H. Many putative endocrine disruptors inhibit prostaglandin synthesis. Environ. Health Perspect. 2011, 119(4):534-541.
34. Kuhn R., Pattard M. Results of the harmful effects of selected water polluants (anilines, phenols, aliphatic compounds) to Daphnia magna. Water Res. 1989, 23:495-499.
35. Kummerer K. Resistance in the environment. J. Antimicrob. Chemother. 2004, 54(2):311-320.
36. Li Z., Fenet H., Gomez E., Chiron S. Transformation of the antiepileptic drug oxcarbazepine upon different water disinfection processes. Water Res. 2011, 45(4):1587-1596.
37. Lister A., Regan C., Van Zwol J., Van Der Kraak G. Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation. Aquat. Toxicol. 2009, 95(4):320-329.
38. Madureira T.V., Rocha M.J., Cruzeiro C., Galante M.H., Monteiro R.A., Rocha E. The toxicity potential of pharmaceuticals found in the Douro River estuary (Portugal): assessing impacts on gonadal maturation with a histopathological and stereological study of zebrafish ovary and testis after sub-acute exposures. Aquat. Toxicol. 2011, 105(3-4):292-299.
39. Mennigen J.A., Martyniuk C.J., Crump K., Xiong H., Zhao E., Popesku J., Anisman H., Cossins A.R., Xia X., Trudeau V.L. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol. Genomics 2008, 35(3):273-282.
40. Moermond C.T., Janssen M.P., de Knecht J.A., Montforts M.H., Peijnenburg W.J., Zweers P.G., Sijm D.T. PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks. Integr. Environ. Assess. Manage. 2012, 8(2):359-371.
41. Nassef M., Kim S.G., Seki M., Kang I.J., Hano T., Shimasaki Y., Oshima Y. In ovo nanoinjection of triclosan, diclofenac and carbamazepine affects embryonic development of medaka fish (Oryzias latipes). Chemosphere 2010, 79(9):966-973.
42. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ. Int. 2007, 33(4):596-601.
43. Saravanan M., Devi K.U., Malarvizhi A., Ramesh M. Effects of Ibuprofen on hematological, biochemical and enzymological parameters of blood in an Indian major carp, Cirrhinus mrigala. Environ. Toxicol. Pharmacol. 2012, 34(1):14-22.
44. Saravanan M., Ramesh M., Petkam R. Alteration in certain enzymological parameters of an Indian major carp, Cirrhinus mrigala exposed to short- and long-term exposure of clofibric acid and diclofenac. Fish Physiol. Biochem. 2013, 39(6):1431-1440.
45. Stackelberg P.E., Furlong E.T., Meyer M.T., Zaugg S.D., Henderson A.K., Reissman D.B. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 2004, 329(1-3):99-113.
46. Talas Z.S., Gulhan M.F. Effects of various propolis concentrations on biochemical and hematological parameters of rainbow trout (Oncorhynchus mykiss). Ecotoxicol. Environ. Saf. 2009, 72(7):1994-1998.
47. Tixier C., Singer H.P., Oellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 2003, 37(6):1061-1068.
48. Triebskorn R., Casper H., Heyd A., Eikemper R., Köhler H.R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2004, 68(2):151-166.
49. Triebskorn R., Casper H., Scheil V., Schwaiger J. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio). Anal. Bioanal. Chem. 2007, 387(4):1405-1416.
50. Vajda A.M., Barber L.B., Gray J.L., Lopez E.M., Woodling J.D., Norris D.O. Reproductive disruption in fish downstream from an estrogenic wastewater effluent. Environ. Sci. Technol. 2008, 42(9):3407-3414.
51. Van den Brandhof E.J., Montforts M. Fish embryo toxicity of carbamazepine, diclofenac and metoprolol. Ecotoxicol. Environ. Saf. 2010, 73(8):1862-1866.
52. Woodling J.D., Lopez E.M., Maldonado T.A., Norris D.O., Vajda A.M. Intersex and other reproductive disruption of fish in wastewater effluent dominated Colorado streams. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2006, 144(1):10-15.
53. Yu Y., Wu L., Chang A.C. Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants. Sci. Total Environ. 2013, 442:310-316.